drugset / Trial / NCT00954811

Luteal Supplementation With Rec-LH After GnRH-agonist Triggering in In Vitro (IVF)

NCT00954811

RandomizedParallel-groupSingle-blindTreatment

Summary

Our aim is to access whether we can achieve equivalent pregnancy rates by the addition of six doses of luteal support with recLH after agonist triggering for IVF cycles in the absence of OHSS.

Timeline

Start
2005-09
Primary completion
2008-01
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject rec-LH Protein / enzyme biologic 300 iu
Comparator Progesterone Other / unclassified 600 mg